Delivery Order SPE2DB24D2205-SPE2DB25FEFCF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,324.81. This firm fixed-price delivery order, with an ultimate completion date of November 14, 2025, was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to federal medical procurement. The place of...
- The Defense Logistics Agency awarded a Delivery Order (4570100654) to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count) with a ceiling value of $3,489.33. This is a firm fixed-price delivery order awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $13,755.84. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Rifampin 300 mg capsules (30-count units) with a ceiling value of $1,789.57. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100-count), with a contract ceiling value of $28,600.52. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside procurement supporting federal pharmaceutical supply needs. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,619.94. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a ceiling value of $7,799.66. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFCFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,905.41 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Rifampin, an antibiotic commonly used in military and veteran healthcare systems, aligns with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.9k | 7/18/25 |